pulmonary neoplasm
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Newly diagnosed, pathologically documented NSCLC Invasion to the first rib or more superior chest wall Age: 15-74 years old ECOG performance status 0 or 1 Ample organ function No prior chemo-or radiotherapy Signed informed consent
Exclusion criteria
Exclusion criteria: Metastasis to, or involvement of, mediastinal node (N2) Distant metastasis or dissemination to pleura/pericardium Active concomitant malignancy Unstable angina, recent myocardial infarction, heart failure Uncontrolled diabetes or hypertension Pregnant or lactating women Other severe complications
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 3-year survival rate | — |
Secondary
| Measure | Time frame |
|---|---|
| complete resection rate, post-surgical morbidity/mortality, local control rate | — |
Countries
Japan
Contacts
JCOG9806 Coordinating Office Medical Oncology Division, National Cancer Center Hospital